Concepedia

Larry Z. Shen

LZ

24

Publications

3.7K

Citations

20

H-Index

1995

Active since

Affiliations

Amplyx Pharmaceuticals (United States)(Current)

Procter & Gamble (United States)

Eli Lilly (United States)

Henry Ford Hospital

Baylor University Medical Center

Larry Z. Shen is an author at Amplyx Pharmaceuticals (United States) specializing in statistics, medicine, and statistical inference.

Top concepts

Publications per year

1995–2024

24

Publications

24

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

Orville Kolterman, Dennis Dong Hwan Kim, Larry Z. Shen et al. · American Journal of Health-System Pharmacy · 2005 · 434 citations

Continual Reassessment Method: A Likelihood Approach

John O’Quigley, Larry Z. Shen · Biometrics · 1996 · 369 citations

, , +14

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

Mark Fineman, Thomas A. Bicsak, Larry Z. Shen et al. · Diabetes Care · 2003 · 355 citations · Full text

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

John B. Buse, Daniel J. Drucker, Kristin Taylor et al. · Diabetes Care · 2010 · 347 citations · Full text

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial

Robert E. Ratner, Richard A. Dickey, Mark Fineman et al. · Diabetic Medicine · 2004 · 303 citations

Rows per page

1–5 of 24